Bristol-Myers Squibb raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus. Click here to find out why BMY is a Buy.

The venture capital arms of Nvidia and Google have backed Swedish startup Lovable in a $330 million Series B round that values the vibe coding platform at $6.6 billion. The investment triples ...

American Healthcare REIT's strengths come from a growing portfolio and future pipeline, macro demand for senior care and ...

While 2025 was the year of the cautious consumer, foodservice franchisees are optimistic about more stability next year and ...

US stocks slide at midday as tech sells off, with Oracle and Broadcom leading losses amid rising AI margin concerns.

By now, you've probably written your fair share of prompts for AI chatbots like Gemini or ChatGPT. With powerful large ...

Explore the defining moments of 2025's volatile markets. Including Nvidia's rise to a $5 trillion valuation, Trump’s tariff ...

Shares of Canopy Growth entered the new trading week with notable volatility following a significant pullback. This movement ...

The investment case for European Lithium presents a study in contrasts. On one hand, surging commodity prices and strong ...

Silver is the strongest focus at the end of 2025 as it has been for decades. Driven by massive investment demand, its ...

Attackers are exploiting a Flight protocol validation failure that allows them to execute arbitrary code without ...

Real estate stocks and funds are set to surge as investors anticipate lower interest rates and inflation. 3 stocks to watch in 2026: Rocket Companies, Redfin, and Zillow.